Search
-
Ebola vaccine trials fast-tracked by international consortium
Media
Unprecedented international consortium assembled to accelerate collaborative multi-site trials of candidate Ebola vaccine
https://www.gsk.com/en-gb/media/press-releases/ebola-vaccine-trials-fast-tracked-by-international-consortium/
First published: 28 August 2014
-
GSK update on current development status of the GSK/NIH Ebola vaccine candidate
Media
GSK is working WHO to accelerate development of our investigational Ebola vaccine and to ramp up production as quickly as possible
https://www.gsk.com/en-gb/media/press-releases/gsk-update-on-current-development-status-of-the-gsknih-ebola-vaccine-candidate/
First published: 18 October 2014
-
GSK statement on Oxford University phase I trial results of an Ebola candidate vaccine
Media
Results from a phase I trial published by Oxford University show that a GSK/NIH Ebola vaccine demonstrated an acceptable safety profile
https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-oxford-university-phase-i-trial-results-of-an-ebola-candidate-vaccine/
First published: 28 January 2015
-
GSK statement on first phase 1 trial results of a candidate Ebola vaccine
Media
Results from phase 1 trial published in NEJM show that GSK/NIH Ebola candidate vaccine was well-tolerated in the 20 healthy adult volunteers
https://www.gsk.com/en-gb/media/press-releases/gsk-statement-on-first-phase-1-trial-results-of-a-candidate-ebola-vaccine/
First published: 26 November 2014
-
GSK grants exclusive technology license for clinical-stage Ebola vaccines to Sabin Vaccine Institute
Media
Transfer from GSK and partnership with NIAID will enable Sabin to advance development of the candidate vaccines
https://www.gsk.com/en-gb/media/press-releases/gsk-grants-exclusive-technology-license-for-clinical-stage-ebola-vaccines-to-sabin-vaccine-institute/
First published: 06 August 2019
-
New European consortium formed to help further advance development of a GSK/NIH Ebola candidate vaccine
Media
Consortium includes GSK and research partners from Oxford, Centre Hospitalier Universitaire Vaudois in Lausanne and the Bernhard-Nocht
https://www.gsk.com/en-gb/media/press-releases/new-european-consortium-formed-to-help-further-advance-development-of-a-gsknih-ebola-candidate-vaccine/
First published: 16 December 2014
-
Major milestone for GSK/NIH candidate Ebola vaccine as first doses shipped to Liberia for use in phase III clinical trial
Media
Healthcare workers among those to be vaccinated in large-scale trial involving up to 30,000 people due to start in the coming weeks
https://www.gsk.com/en-gb/media/press-releases/major-milestone-for-gsknih-candidate-ebola-vaccine-as-first-doses-shipped-to-liberia-for-use-in-phase-iii-clinical-trial/
First published: 23 January 2015
-
Ebola Vaccine Journey Infographic
Media
https://www.gsk.com/media/2989/ebola-vaccine-journey-infographic.pdf
First published: 27 February 2017
-
Save the Children partnership infographic
Media
https://www.gsk.com/media/5747/gsk_stc_infographic_sep19-111019.pdf
First published: 31 October 2019
-
Save the Children partnership infographic
Media
https://www.gsk.com/media/2988/save-the-children-infographic.pdf
First published: 19 November 2018